Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
46 studies found for:    " June 08, 2011":" July 08, 2011"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" June 08, 2011":" July 08, 2011"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Safety and Tolerability of Crofelemer for HIV-Associated Diarrhea
Conditions: HIV Enteropathy;   Diarrhea With HIV
Intervention: Drug: Crofelemer
2 Recruiting HIV, Buprenorphine, and the Criminal Justice System
Conditions: Human Immunodeficiency Virus;   Acquired Immunodeficiency Syndrome;   Opiate Addiction;   Drug Dependence
Intervention: Drug: Buprenorphine/naloxone
3 Completed
Has Results
A Study to Compare Brachial Artery Reactivity and Cardiovascular Risk of a Treatment Simplification by Darunavir/Ritonavir (DRV/r) 800/100 mg Versus a Triple Combination Therapy Containing DRV/r in HIV-1 Infected Patients
Condition: Human Immunodeficiency Virus 1
Interventions: Drug: Darunavir(DRV);   Drug: Ritonavir;   Drug: 2 nucleoside reverse transcriptase inhibitors (NRTIs)
4 Completed Feasibility of a Stigma Reduction Intervention for Human Immunodeficiency Virus (HIV)-Infected Women
Conditions: Human Immunodeficiency Virus (HIV);   Self-efficacy;   Self-esteem
Intervention: Behavioral: Ipod video
5 Completed HIV Diagnosis in Hospitalized Malawian Infants
Condition: HIV Infections
Intervention: Device: Point of care HIV RNA PCR
6 Completed Relative Bioavailability Study of a Pediatric Granule Formulation of Dolutegravir
Condition: Infections, Human Immunodeficiency Virus and Herpesviridae
Interventions: Drug: Dolutegravir 50 mg tablet;   Drug: Dolutegravir 50 mg oral granules
7 Recruiting Connect to Protect (C2P): Building a Community-Based Infrastructure for HIV Prevention
Condition: HIV Infection
Intervention: Behavioral: Community Mobilization
8 Completed Non-interventional Study on Use of Darunavir With Ritonavir in Clinical Practice
Condition: HIV Infections
Intervention: Drug: darunavir/ritonavir plus background regimen
9 Recruiting HIV Attachment Inhibitor to Treat Human Immunodeficiency Virus 1 (HIV-1) Infections
Condition: Human Immunodeficiency Virus-1
Interventions: Drug: BMS-663068;   Drug: Raltegravir;   Drug: Tenofovir;   Drug: Ritonavir;   Drug: Atazanavir
10 Unknown  Immune Response to Seasonal Influenza Vaccine in HIV Infected Individuals
Conditions: Influenza, Human;   Human Immunodeficiency Virus I Infection
Intervention:
11 Active, not recruiting Safety of and Immune Response to a DNA HIV Vaccine Boosted With a Modified Vaccinia HIV Vaccine and Protein HIV Vaccine in Healthy Adults
Conditions: HIV Seronegativity;   HIV Preventive Vaccine
Interventions: Biological: MVA-C + gp140/MF59;   Biological: DNA-C2 + MVA-C;   Biological: DNA-C2 + MVA-C + gp140/MF59
12 Completed Residual Risk Assessment Of HIV Transmission
Condition: HIV Infection
Intervention: Biological: blood and semen sampling, specific biological exams and biobank and self administered questionnaires
13 Completed Post-marketing Safety Surveillance Program in Human Immunodeficiency Virus (HIV)-Infected Children Exposed to Atazanavir in Europe
Condition: HIV Infection
Intervention:
14 Recruiting REMEMBER: Reducing Early Mortality & Morbidity by Empiric Tuberculosis (TB) Treatment
Condition: HIV Infection
Interventions: Drug: Atripla (r);   Drug: Efavirenz;   Drug: Truvada;   Drug: Rifampin/isoniazid/pyrazinamide/ethambutol FDC;   Drug: Rifampin/isoniazid FDC
15 Unknown  Safety and Effectiveness of Tenofovir Gel in the Prevention of Human Immunodeficiency Virus (HIV-1) Infection in Women and the Effects of Tenofovir Gel on the Incidence of Herpes Simplex Virus (HSV-2) Infection
Condition: HIV Prevention
Interventions: Drug: Tenofovir gel;   Drug: Universal placebo gel
16 Active, not recruiting Evaluating the Safety and Immune Response to an HIV Vaccine in Healthy, HIV-Uninfected Adults Who Have Participated in Previous HIV Vaccine Clinical Trials and in Adults Who Have Not Participated in Previous HIV Vaccine Clinical Trials
Condition: HIV Infections
Interventions: Biological: Sub C gp140 Vaccine;   Biological: MF59C.1 Adjuvant
17 Completed Effect of Multiple Dosing With BI 201335 on the Pharmacokinetics of Darunavir Co-administered With Ritonavir in Healthy Male and Female Volunteers
Condition: HIV Infections
Interventions: Drug: Darunavir;   Drug: Ritonavir;   Drug: BI 201335
18 Completed Treating South African Pregnant Women for Methamphetamine
Conditions: HIV;   Drug Addiction
Interventions: Behavioral: Psycho-education;   Behavioral: Experimental
19 Recruiting Project FIRST - Financial Incentives to Reduce Substance Use and Improve Treatment
Conditions: HIV;   Opiate Dependence
Interventions: Behavioral: Abstinence-reinforcing contingency management intervention;   Behavioral: Performance Feedback intervention
20 Unknown  Trial of Safe Water Storage Among People Living With HIV
Conditions: Diarrhea;   Waterborne Disease;   HIV
Intervention: Device: Safe storage device

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years